Nanoemulsion enhances α-tocopherol succinate bioavailability in rats
In conclusion, our laboratory-made NE was a safe drug delivery system for clinical trials and could be a promising formulation for α-TOS by I.V administration. Graphical abstract
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Drugs & Pharmacology | Epithelial Cancer | Laboratory Medicine | Mitochondria | Nanotechnology | Oral Cancer | Study | Vitamins